Radiotherapy modulates expression of EGFR, ERCC1 and p53 in cervical cancer

Cervical cancer is a public health problem and the molecular mechanisms underlying radioresistance are still poorly understood. Here, we evaluated the modulation of key molecules involved in cell proliferation, cell cycle and DNA repair in cervical cancer cell lines (CASKI and C33A) and in malignant...

Full description

Bibliographic Details
Main Author: de Almeida,V.H. (author)
Other Authors: de Melo,A.C. (author), Meira,D.D. (author), Pires,A.C. (author), Nogueira-Rodrigues,A. (author), Pimenta-Inada,H.K. (author), Alves,F.G. (author), Moralez,G. (author), Thiago,L.S. (author), Ferreira,C.G. (author), Sternberg,C. (author)
Format: article
Language:eng
Published: 2018
Subjects:
Cervical cancer
Radiotherapy
Epidermal growth factor receptor (EGFR)
p53
Excision repair cross-complementation group 1 (ERCC1)
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2018000100608
Country:Brazil
Oai:oai:scielo:S0100-879X2018000100608

Internet

http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2018000100608

Similar Items